159 related articles for article (PubMed ID: 7773353)
1. Transcatheter arterial chemoembolization therapy with epirubicin hydrochloride, mitomycin C-iohexol-Lipiodol emulsion (EMILE) for hepatocellular carcinoma.
Kanematsu M
J Gastroenterol; 1995 Apr; 30(2):215-23. PubMed ID: 7773353
[TBL] [Abstract][Full Text] [Related]
2. [Superselective bronchial arterial infusion therapy with cisplatin and epirubicin hydrochloride, mitomycin C-iohexol-Lipiodol emulsion (EMILE) for hilar lung adenocarcinoma: preliminary clinical experience].
Kanematsu M; Yamawaki Y; Matsui E; Mochizuki R; Goto H; Asada S; Imaeda T; Shibayama M; Doi H
Nihon Igaku Hoshasen Gakkai Zasshi; 1993 Sep; 53(9):1073-5. PubMed ID: 8414933
[TBL] [Abstract][Full Text] [Related]
3. A phase II trial of transcatheter arterial infusion chemotherapy with an epirubicin-Lipiodol emulsion for advanced hepatocellular carcinoma refractory to transcatheter arterial embolization.
Tanaka T; Ikeda M; Okusaka T; Ueno H; Morizane C; Ogura T; Hagihara A; Iwasa S
Cancer Chemother Pharmacol; 2008 Apr; 61(4):683-8. PubMed ID: 17541589
[TBL] [Abstract][Full Text] [Related]
4. Therapeutic effect of a CDDP-epirubicin-Lipiodol emulsion on advanced hepatocellular carcinoma.
Ichida T; Kato M; Hayakawa A; Ito S; Mori S; Sato T; Sugitani S; Sato H; Watanabe M; Asakura H
Cancer Chemother Pharmacol; 1994; 33 Suppl():S74-8. PubMed ID: 8137488
[TBL] [Abstract][Full Text] [Related]
5. Interventional radiology for advanced hepatocellular carcinoma: comparison of hepatic artery infusion chemotherapy and transcatheter arterial lipiodol chemoembolization.
Sumie S; Yamashita F; Ando E; Tanaka M; Yano Y; Fukumori K; Sata M
AJR Am J Roentgenol; 2003 Nov; 181(5):1327-34. PubMed ID: 14573429
[TBL] [Abstract][Full Text] [Related]
6. [Transcatheter oily chemoembolization and intermittent hepatic artery infusion chemotherapy in the management of advanced hepatocellular carcinoma].
Miura T; An M; Matsumoto Y; Terakado H; Murata M; Takagi S; Ikawa M; Hamada E; Watanabe K; Nakasato S
Gan To Kagaku Ryoho; 1998 Jul; 25(9):1262-5. PubMed ID: 9703803
[TBL] [Abstract][Full Text] [Related]
7. Repeated arterial infusion chemotherapy for inoperable hepatocellular carcinoma using an implantable drug delivery system.
Iwamiya T; Sawada S; Ohta Y
Cancer Chemother Pharmacol; 1994; 33 Suppl():S134-8. PubMed ID: 8137474
[TBL] [Abstract][Full Text] [Related]
8. Comparison of transcatheter arterial chemoembolization and transcatheter arterial chemotherapy infusion for patients with intermediate-stage hepatocellular carcinoma.
Nishikawa H; Osaki Y; Kita R; Kimura T; Ohara Y; Takeda H; Sakamoto A; Saito S; Nishijima N; Nasu A; Komekado H; Nishiguchi S
Oncol Rep; 2014 Jan; 31(1):65-72. PubMed ID: 24220763
[TBL] [Abstract][Full Text] [Related]
9. A randomized trial of intrahepatic arterial infusion of 4'-epidoxorubicin with Lipiodol versus 4'-epidoxorubicin alone in the treatment of hepatocellular carcinoma.
Yoshikawa M; Saisho H; Ebara M; Iijima T; Iwama S; Endo F; Kimura M; Shimamura Y; Suzuki Y; Nakano T
Cancer Chemother Pharmacol; 1994; 33 Suppl():S149-52. PubMed ID: 8137478
[TBL] [Abstract][Full Text] [Related]
10. A retrospective comparative study of epirubicin-lipiodol emulsion and cisplatin-lipiodol suspension for use with transcatheter arterial chemoembolization for treatment of hepatocellular carcinoma.
Yodono H; Matsuo K; Shinohara A
Anticancer Drugs; 2011 Mar; 22(3):277-82. PubMed ID: 21360850
[TBL] [Abstract][Full Text] [Related]
11. Use of transcatheter arterial infusion of anticancer agents with lipiodol to prevent recurrence of hepatocellular carcinoma after hepatic resection.
Tanaka K; Shimada H; Togo S; Takahashi T; Endo I; Sekido H; Yoshida T
Hepatogastroenterology; 1999; 46(26):1083-8. PubMed ID: 10370671
[TBL] [Abstract][Full Text] [Related]
12. Disposition of epirubicin after intraarterial administration in Lipiodol to patients with hepatocellular carcinoma.
Dodds HM; Walpole ET; Rivory LP; Strong RW; Pond SM
Ther Drug Monit; 1996 Oct; 18(5):537-43. PubMed ID: 8885116
[TBL] [Abstract][Full Text] [Related]
13. Epirubicin-Lipiodol chemotherapy versus 131iodine-Lipiodol radiotherapy in the treatment of unresectable hepatocellular carcinoma.
Bhattacharya S; Novell JR; Dusheiko GM; Hilson AJ; Dick R; Hobbs KE
Cancer; 1995 Dec; 76(11):2202-10. PubMed ID: 8635022
[TBL] [Abstract][Full Text] [Related]
14. Prospective evaluation of transcatheter arterial chemoembolization (TACE) with multiple anti-cancer drugs (epirubicin, cisplatin, mitomycin c, 5-fluorouracil) compared with TACE with epirubicin for treatment of hepatocellular carcinoma.
Sahara S; Kawai N; Sato M; Tanaka T; Ikoma A; Nakata K; Sanda H; Minamiguchi H; Nakai M; Shirai S; Sonomura T
Cardiovasc Intervent Radiol; 2012 Dec; 35(6):1363-71. PubMed ID: 22358993
[TBL] [Abstract][Full Text] [Related]
15. Risk factors for the leakage of chemotherapeutic agents into systemic circulation after transcatheter arterial chemoembolization of hepatocellular carcinoma.
Hsieh MY; Lin ZY; Chen SH; Chuang WL
Kaohsiung J Med Sci; 2011 Oct; 27(10):431-6. PubMed ID: 21943814
[TBL] [Abstract][Full Text] [Related]
16. Overall survival after transarterial lipiodol infusion chemotherapy with or without embolization for unresectable hepatocellular carcinoma: propensity score analysis.
Takayasu K; Arii S; Ikai I; Kudo M; Matsuyama Y; Kojiro M; Makuuchi M;
AJR Am J Roentgenol; 2010 Mar; 194(3):830-7. PubMed ID: 20173167
[TBL] [Abstract][Full Text] [Related]
17. Evaluation of transcatheter arterial embolization with epirubicin-lipiodol emulsion for hepatocellular carcinoma.
Aoyama K; Tsukishiro T; Okada K; Tsuchida T; Aiba N; Nambu S; Miyabayashi C; Yasuyama T; Higuchi K; Watanabe A
Cancer Chemother Pharmacol; 1992; 31 Suppl():S55-9. PubMed ID: 1281046
[TBL] [Abstract][Full Text] [Related]
18. [Successful preparation of mitoxantrone emulsion containing non-ionic contrast medium].
Ichikawa W; Nihei Z; Sawai S; Yamashita T; Uetake H; Kawachi Y; Hirayama R; Mishima Y; Tamaru H
Gan To Kagaku Ryoho; 1992 Aug; 19(10 Suppl):1550-2. PubMed ID: 1326920
[TBL] [Abstract][Full Text] [Related]
19. High-dose iodized oil transcatheter arterial chemoembolization for patients with large hepatocellular carcinoma.
Chen MS; Li JQ; Zhang YQ; Lu LX; Zhang WZ; Yuan YF; Guo YP; Lin XJ; Li GH
World J Gastroenterol; 2002 Feb; 8(1):74-8. PubMed ID: 11833075
[TBL] [Abstract][Full Text] [Related]
20. Total necrosis of hepatocellular carcinoma with a combination therapy of arterial infusion of chemotherapeutic lipiodol and transcatheter arterial embolization: report of 14 cases.
Kenji J; Hyodo I; Tanimizu M; Tanada M; Nishikawa Y; Hosokawa Y; Mandai K; Moriwaki S
Semin Oncol; 1997 Apr; 24(2 Suppl 6):S6-71-S6-80. PubMed ID: 9151920
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
